Tag Archives: BIOTRONIK SE & Co. KG

Orsiro From BIOTRONIK, Industry’s First Hybrid Drug-Eluting Stent, Performs as Best in Class

Positive 9 Month Results From BIOFLOW-II Clinical Trial and 12 Month Results From BIOFLOW-III Registry Presented at EuroPCR Congress BUELACH, SWITZERLAND–(Marketwired / Asianet-Pakistan – May 31, 2013) – Primary end-point results from the BIOFLOW-II Clinical Study demonstrating the non-inferiority of

أجهزة بيوترونيك Ilesto 7 ICD/CRT-D Series بتكنولوجيا (R) ProMRI تحصل على اعتماد الجودة الأوروبية

برلين–(Marketwire / Asianet-Pakistan – 18 فبراير 2013) – أعلنت اليوم BIOTRONIK  (بيوترونيك) الرائدة في مجال تصنيع التقنيات الطبية لمرضى القلب في أعقاب احتفالها بالذكرى السنوية رقم 50 في عام 2013 عن حصول أجهزة Ilesto 7 الخاصة بإزالة الرجفان القابلة للزرع/

BIOTRONIK Ilesto 7 ICD/CRT-D Series With ProMRI(R) Technology Gains CE Approval

BERLIN–(Marketwire / Asianet-Pakistan – February 15, 2013) –  BIOTRONIK, the leading manufacturer of cardiovascular medical technology that is celebrating its 50th anniversary in 2013, announced today that the Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D) series has received CE

Successful HBI and BIOTRONIK Partnership Saves 1,000 Lives – Now Reaching Out to More Countries

BIOTRONIK Renews Commitment After Achieving Their First Milestone of Providing 1,000 Life Saving Devices One Year Earlier Than Expected BERLIN–(Marketwire/Asianet-Pakistan – October 1, 2012) –  BIOTRONIK, a leading manufacturer of [...]

EPIC Alliance Gets to “The Heart of the Matter” at ESC Congress 2012

BERLIN–(Marketwire/Asianet-Pakistan – September 10, 2012) – Female electrophysiologists from around the world gathered on August 28th, 2012 at the European Society of Cardiology Congress to attend the EPIC Alliance’s scientific [...]